CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

Scope & Guideline

Transforming pharmaceutical science through critical reviews.

Introduction

Delve into the academic richness of CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0743-4863
PublisherBEGELL HOUSE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1984 to 2024
AbbreviationCRIT REV THER DRUG / Crit. Rev. Ther. Drug Carr. Syst.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address50 NORTH ST, DANBURY, CT 06810

Aims and Scopes

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS aims to provide a comprehensive platform for the dissemination of innovative research and reviews in the field of drug delivery systems. The journal emphasizes critical analysis and synthesis of contemporary findings, methodologies, and technologies that advance therapeutic drug carriers.
  1. Nanotechnology in Drug Delivery:
    The journal focuses on the application of nanotechnology for enhancing drug delivery systems, including the development of nanoparticles, liposomes, and nanocarriers that improve the efficacy and targeting of therapeutic agents.
  2. Innovative Drug Delivery Systems:
    It covers various innovative approaches and technologies, such as 3D printing and in situ gels, that aim to revolutionize drug administration routes and improve patient compliance.
  3. Theranostics:
    The journal emphasizes the integration of therapeutic and diagnostic capabilities within drug delivery systems, allowing for personalized medicine and improved disease management.
  4. Mechanistic Insights and Stability Challenges:
    Research articles delve into the mechanistic aspects of drug delivery systems, including stability challenges of formulations and the physicochemical properties that influence drug release.
  5. Natural and Plant-Based Systems:
    There is a growing interest in utilizing natural products and plant-based materials as drug delivery vehicles, highlighting their potential in therapeutic applications.
  6. Targeted Delivery Strategies:
    The journal discusses advancements in targeted delivery methods, including receptor-targeted and site-specific delivery systems for various diseases, particularly cancer.
Recent publications in CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS have highlighted several emerging themes that are gaining traction in the field of drug delivery. These themes reflect the evolving landscape of therapeutic approaches and the integration of innovative technologies.
  1. 3D Printing for Personalized Medicine:
    The exploration of 3D printing technologies for creating personalized drug delivery systems is on the rise, showcasing its potential to tailor therapies to individual patient needs.
  2. Theranostic Applications:
    There's an increasing interest in theranostic approaches that combine therapy and diagnostics in one system, particularly in oncology, where targeted treatment and monitoring are crucial.
  3. Non-Invasive Delivery Systems:
    The trend towards non-invasive delivery methods, such as transdermal and oral dispersible films, is gaining momentum, aimed at improving patient compliance and reducing side effects.
  4. Natural and Biodegradable Materials:
    Research is increasingly focusing on natural and biodegradable materials for drug delivery systems, emphasizing sustainability and biocompatibility in therapeutic applications.
  5. Applications of Cannabinoids and Novel Therapies:
    The therapeutic potential of cannabinoids and other novel compounds is emerging, particularly in pain management and other chronic conditions, reflecting broader trends in integrative and alternative medicine.
  6. Targeted Nanocarriers for Cancer Therapy:
    There is a significant increase in studies related to targeted nanocarriers for cancer treatment, focusing on enhancing specificity and reducing systemic toxicity.

Declining or Waning

While CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS consistently explores a broad range of topics, certain areas appear to be losing prominence based on recent publication trends. The following themes have been noted for their declining frequency in the journal.
  1. Traditional Drug Formulation Techniques:
    There seems to be a decreasing focus on conventional drug formulation methods, as the journal shifts towards more advanced and innovative delivery systems that leverage nanotechnology and biocompatible materials.
  2. General Reviews Without Novelty:
    The journal is moving away from general reviews that do not offer new insights or advancements. There is a preference for papers that provide critical evaluations of recent advancements or propose novel methodologies.
  3. Invasive Drug Delivery Methods:
    As non-invasive delivery methods gain traction, the prevalence of discussions surrounding invasive drug delivery techniques appears to be waning, reflecting a broader trend in patient-centered care.

Similar Journals

ADVANCED DRUG DELIVERY REVIEWS

Pioneering Insights for Pharmaceutical Excellence.
Publisher: ELSEVIERISSN: 0169-409XFrequency: 12 issues/year

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Connecting scholars to tackle health challenges in the tropics.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

JOURNAL OF PHARMACY AND PHARMACOLOGY

Elevating pharmaceutical sciences to new heights.
Publisher: OXFORD UNIV PRESSISSN: 0022-3573Frequency: 12 issues/year

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

DRUG DELIVERY

Pioneering Breakthroughs in Pharmaceutical Sciences
Publisher: TAYLOR & FRANCIS LTDISSN: 1071-7544Frequency: 1 issue/year

DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.

Pharmaceutical Sciences

Advancing pharmaceutical knowledge for a healthier future.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

Journal of Reports in Pharmaceutical Sciences

Innovating Drug Development Through Groundbreaking Research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2322-1232Frequency: 2 issues/year

Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.

Expert Opinion on Drug Delivery

Catalyzing Progress in Pharmacology and Pharmaceutics
Publisher: TAYLOR & FRANCIS LTDISSN: 1742-5247Frequency: 12 issues/year

Expert Opinion on Drug Delivery is a leading journal in the field of pharmaceutical science, published by Taylor & Francis Ltd. With an impressive impact factor and a prestigious Q1 ranking in 2023, it stands out as a vital resource for researchers, professionals, and students dedicated to advancing drug delivery technologies. Established in 2004, the journal has consistently provided a platform for critical insights and expert analyses, bridging the gap between innovation and application in drug delivery systems. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to the fields of pharmacology, toxicology, and pharmaceutics. With its robust ranking of 13th out of 183 in Scopus, the journal continues to foster discourse and collaboration among experts, thereby enhancing the advancement of therapeutic options and improving patient outcomes.

AAPS Journal

Elevating Standards in Pharmaceutical Research and Methodologies.
Publisher: SPRINGERISSN: 1550-7416Frequency: 1 issue/year

AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.

MOLECULAR PHARMACEUTICS

Pioneering Research in Drug Development and Molecular Medicine
Publisher: AMER CHEMICAL SOCISSN: 1543-8384Frequency: 6 issues/year

MOLECULAR PHARMACEUTICS, published by the American Chemical Society, stands as a pivotal journal within the fields of Drug Discovery, Molecular Medicine, and Pharmaceutical Science, as evidenced by its impressive rankings in various categories, including Q1 in Drug Discovery and Pharmaceutical Science. With an ISSN of 1543-8384 and an E-ISSN of 1543-8392, this journal has been at the forefront of research since its inception in 2004 and continues to foster innovation and collaboration among researchers, professionals, and students well into 2024. The journal is noted for its significant impact, having achieved a Scopus ranking of #31 in Pharmaceutical Science and #36 in Drug Discovery, placing it in the top percentiles of the respective fields. While it currently does not offer Open Access, MOLECULAR PHARMACEUTICS remains an essential resource for advancing the understanding of molecular mechanisms in drug development and therapeutic strategies, ensuring that cutting-edge findings reach a wide audience and contribute to the progression of pharmaceutical sciences.

Journal of Pharmaceutical Investigation

Exploring the forefront of pharmaceutical sciences for a healthier tomorrow.
Publisher: SPRINGERNATUREISSN: 2093-5552Frequency: 6 issues/year

Journal of Pharmaceutical Investigation, published by SPRINGERNATURE, is a leading academic resource in the field of pharmaceutical sciences, offering critical insights and innovative research findings. With an impact factor that underscores its significance, this journal ranks in the Q1 category for both Pharmacology and Pharmaceutical Science as of 2023, showcasing its high-quality publications and rigorous peer-review processes. Operating from the Netherlands, the journal spans from 2012 to 2024, offering a rich archive of interdisciplinary research contributions that advance knowledge in pharmacology, toxicology, and pharmaceutics. It holds impressive Scopus rankings, placing it among the top-tier journals in its categories, which enhances its appeal to researchers, professionals, and students aiming to publish their work or stay up-to-date with the latest advancements in the pharmaceutical field. Engaging with the Journal of Pharmaceutical Investigation not only enriches your understanding but also connects you with a community dedicated to advancing healthcare and therapeutic innovations.